Organon tripled sales of the bleeding-control system from 2022 to 2024 and is on track to grow sales again this year.

MMI won the FDA’s OK to study robotic surgery for Alzheimer’s disease. Elsewhere, SS Innovations’ CEO performed remote bypass ...